Company: TBPH
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001104659-25-033819
Chunk: 2

Company: Theravance Biopharma, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 2
---
 Corporate Governance Policies                                                                                             | ​ | ​ | ​ | ​ | 40 | ​ | ​ |

i

TABLE OF CONTENTS

| ​ | Advisory Vote on Executive Compensation                                     | ​ | ​ | ​ | ​ | 40 | ​ | ​ |
| ​ | Pay-Versus-Performance                                                      | ​ | ​ | ​ | ​ | 41 | ​ | ​ |
| ​ | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT              | ​ | ​ | ​ | ​ | 45 | ​ | ​ |
| ​ | EQUITY COMPENSATION PLAN INFORMATION                                        | ​ | ​ | ​ | ​ | 48 | ​ | ​ |
| ​ | RELATED PARTY TRANSACTIONS                                                  | ​ | ​ | ​ | ​ | 49 | ​ | ​ |
| ​ | Indemnification Agreements                                                  | ​ | ​ | ​ | ​ | 49 | ​ | ​ |
| ​ | Winningham Restricted Share Purchase Agreement                              | ​ | ​ | ​ | ​ | 49 | ​ | ​ |
| ​ | Review, Approval or Ratification of Transactions with Related Persons       | ​ | ​ | ​ | ​ | 49 | ​ | ​ |
| ​ | SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE                     | ​ | ​ | ​ | ​ | 50 | ​ | ​ |
| ​ | AUDIT COMMITTEE REPORT                                                      | ​ | ​ | ​ | ​ | 51 | ​ | ​ |
| ​ | Role of the Audit Committee                                                 | ​ | ​ | ​ | ​ | 51 | ​ | ​ |
| ​ | Review of Audited Financial Statements for the Year Ended December 31, 2024 | ​ | ​ | ​ | ​ | 51 | ​ | ​ |
| ​ | OTHER MATTERS                                                               | ​ | ​ | ​ | ​ | 53 | ​ | ​ |

ii

TABLE OF CONTENTS THERAVANCE BIOPHARMA, INC. c/o Theravance Biopharma US, LLC
901 Gateway Boulevard
South San Francisco, CA 94080 PROXY STATEMENT FOR
2025 ANNUAL GENERAL MEETING This proxy statement is furnished in connection with a solicitation of proxies by our board of directors for use at the 2025 Annual General Meeting (the “Annual Meeting”) to be held at 5:00 pm Irish Time (“IT”) on May 19, 2025, and any adjourn